Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 2994-3001

  Vangelista, Luca ^a   Secchi, Massimiliano ^a   Liu, Xiaowen ^b   Bachi, Angela ^a   Jia, Letong ^b   Xu, Qiang ^b   Lusso, Paolo ^a,c,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Osel Inc   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; PROBIOTIC AGENT; RANTES; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CCR5 ANTAGONIST;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; LACTOBACILLUS; LACTOBACILLUS JENSENII; MACROPHAGE; PRIORITY JOURNAL; VIRUS INHIBITION; CELL CULTURE; DRUG EFFECTS; GENETICS; HIV INFECTIONS; ION EXCHANGE CHROMATOGRAPHY; METABOLISM; VIROLOGY; WESTERN BLOTTING;

ANTI-HIV AGENTS; BLOTTING, WESTERN; CCR5 RECEPTOR ANTAGONISTS; CELLS, CULTURED; CHEMOKINE CCL5; CHROMATOGRAPHY, ION EXCHANGE; HIV INFECTIONS; HIV-1; HUMANS; LACTOBACILLUS;

EID: 77953756392     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01492-09     Document Type: Article

References (37)

1. Bolton, M., A. van der Straten, and C. R. Cohen. 2008. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex. Transm. Dis. 35:214-225.
2. Boyd, M. R., K. R. Gustafson, J. B. McMahon, R. H. Shoemaker, B. R. O'Keefe, T. Mori, R. J. Gulakowski, L. Wu, M. I. Rivera, C. M. Laurencot, M. J. Currens, J. H. Cardellina II, R. W. Buckheit, Jr., P. L. Nara, L. K. Pannell, R. C. Sowder II, and L. E. Henderson. 1997. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41:1521-1530.
3. Chancey, C. J., K. V. Khanna, J. F. Seegers, G. W. Zhang, J. Hildreth, A. Langan, and R. B. Markham. 2006. Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer. J. Immunol. 176:5627-5636.
4. Chang, T. L., C. Chang, D. A. Simpson, Q. Xu, P. K. Martin, L. A. Lagenaur, G. K. Schoolnik, D. D. Ho, S. L. Hillier, M. Holodniy, J. A. Lewicki, and P. P. Lee. 2003. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc. Natl. Acad. Sci. U. S. A. 100:11672-11677.
5. Cherpes, T. L., M. A. Melan, J. A. Kant, L. A. Cosentino, L. A. Meyn, and S. L. Hillier. 2005. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B streptococcus colonization. Clin. Infect. Dis. 40:1422-1428.
6. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1αα, and MIP-1 as the major HIV-suppressive factors produced by CD8++ T cells. Science 270: 1811-1815. (Pubitemid 3011045)
7. Cutler, B., and J. Justman. 2008. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect. Dis. 8:685-697.
8. Gaertner, H., F. Cerini, J. M. Escola, G. Kuenzi, A. Melotti, R. Offord, I. Rossitto-Borlat, R. Nedellec, J. Salkowitz, G. Gorochov, D. Mosier, and O. Hartley. 2008. Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide. Proc. Natl. Acad. Sci. U. S. A. 105: 17706-17711.
9. Giomarelli, B., R. Provvedi, F. Meacci, T. Maggi, D. Medaglini, G. Pozzi, T. Mori, J. B. McMahon, R. Gardella, and M. R. Boyd. 2002. The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. AIDS 16:1351-1356.
10. Hladik, F., P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M. J. McElrath. 2007. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26:257-270.
11. Jin, H., I. Kagiampakis, P. Li, and P. J. Liwang. 2010. Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES. Proteins 78:295-308.
12. Kilby, J. M., S. Hopkins, T. M. Venetta, B. DiMassimo, G. A. Cloud, J. Y. Lee, L. Alldredge, E. Hunter, D. Lambert, D. Bolognesi, T. Matthews, M. R. Johnson, M. A. Nowak, G. M. Shaw, and M. S. Saag. 1998. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1302-1307.
13. Lagenaur, L. A., and E. A. Berger. 2005. An anti-HIV microbicide comes alive. Proc. Natl. Acad. Sci. U. S. A. 102:12294-12295.
14. Lederman, M. M., R. S. Veazey, R. Offord, D. E. Mosier, J. Dufour, M. Mefford, M. Piatak, Jr., J. D. Lifson, J. R. Salkowitz, B. Rodriguez, A. Blauvelt, and O. Hartley. 2004. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306:485-487.
15. Liu, J. J., G. Reid, Y. Jiang, M. S. Turner, and C. C. Tsai. 2007. Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14. Cell Microbiol. 9:120-130.
16. Liu, X., L. A. Lagenaur, D. A. Simpson, K. P. Essenmacher, C. L. Frazier-Parker, Y. Liu, D. Tsai, S. S. Rao, D. H. Hamer, T. P. Parks, P. P. Lee, and Q. Xu. 2006. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob. Agents Chemother. 50:3250-3259.
17. Liu, X., L. A. Lagenaur, P. P. Lee, and Q. Xu. 2008. Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules. Appl. Environ. Microbiol. 74:4626-4635.
18. Lusso, P., F. Cocchi, C. Balotta, P. D. Markham, A. Louie, P. Farci, R. Pal, R. C. Gallo, and M. S. Reitz, Jr. 1995. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4++ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69:3712-3720.
19. Lusso, P. 2006. HIV and the chemokine system: 10 years later. EMBO J. 25:447-456.
20. Moscicki, A. B. 2008. Vaginal microbicides: where are we and where are we going? J. Infect. Chemother. 14:337-341.
21. O'Keefe, B. R., S. R. Shenoy, D. Xie, W. Zhang, J. M. Muschik, M. J. Currens, I. Chaiken, and M. R. Boyd. 2000. Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41. Mol. Pharmacol. 58:982-992.
22. Pastore, C., G. R. Picchio, F. Galimi, R. Fish, O. Hartley, R. E. Offord, and D. E. Mosier. 2003. Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES. Antimicrob. Agents Chemother. 47:509-517.
23. Polo, S., V. Nardese, C. De Santis, C. Arcelloni, R. Paroni, F. Sironi, A. Verani, M. Rizzi, M. Bolognesi, and P. Lusso. 2000. Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation. Eur. J. Immunol. 30:3190-3198.
24. Pouwels, P. H., and J. A. Leunissen. 1994. Divergence in codon usage of Lactobacillus species. Nucleic Acids Res. 22:929-936.
25. Proudfoot, A. E., S. Fritchley, F. Borlat, J. P. Shaw, F. Vilbois, C. Zwahlen, A. Trkola, D. Marchant, P. R. Clapham, and T. N. Wells. 2001. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276:10620-10626.
26. Pusch, O., D. Boden, S. Hannify, F. Lee, L. D. Tucker, M. R. Boyd, J. M. Wells, and B. Ramratnam. 2005. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J. Acquir. Immune Defic. Syndr. 40: 512-520.
27. Pusch, O., R. Kalyanaraman, L. D. Tucker, J. M. Wells, B. Ramratnam, and D. Boden. 2006. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli. AIDS 20:1917-1922.
28. Rao, S., S. Hu, L. McHugh, K. Lueders, K. Henry, Q. Zhao, R. A. Fekete, S. Kar, S. Adhya, and D. H. Hamer. 2005. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc. Natl. Acad. Sci. U. S. A. 102:11993-11998.
29. Sakthivel, S. K., U. P. Singh, S. Singh, D. D. Taub, J. U. Igietseme, and J. W. Lillard, Jr. 2008. CCL5 regulation of mucosal chlamydial immunity and infection. BMC Microbiol. 8:136.
30. Secchi, M., Q. Xu, P. Lusso, and L. Vangelista. 2009. The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants. Protein Expr. Purif. 68:34-41.
31. Shaw, J. P., Z. Johnson, F. Borlat, C. Zwahlen, A. Kungl, K. Roulin, A. Harrenga, T. N. Wells, and A. E. Proudfoot. 2004. The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 12:2081-2093.
32. Shen, R., H. E. Richter, R. H. Clements, L. Novak, K. Huff, D. Bimczok, S. Sankaran-Walters, S. Dandekar, P. R. Clapham, L. E. Smythies, and P. D. Smith. 2009. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type-1 infection. J. Virol. 83:3258-3267.
33. Stemmer, W. P., A. Crameri, K. D. Ha, T. M. Brennan, and H. L. Heyneker. 1995. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164:49-53.
34. Taha, T. E., D. R. Hoover, G. A. Dallabetta, N. I. Kumwenda, L. A. Mtimavalye, L. P. Yang, G. N. Liomba, R. L. Broadhead, J. D. Chiphangwi, and P. G. Miotti. 1998. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12:1699-1706.
35. Thapa, M., W. A. Kuziel, and D. J. Carr. 2007. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81:3704-3713.
36. Vangelista, L., M. Secchi, and P. Lusso. 2008. Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine 26:3008-3015.
37. Yu, R. R., A. T. Cheng, L. A. Lagenaur, W. Huang, D. E. Weiss, J. Treece, B. E. Sanders-Beer, D. H. Hamer, P. P. Lee, Q. Xu, and Y. Liu. 2009. A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development. J. Med. Primatol. 38:125-136.